News

In The News ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
In The News Director Lindsay Bealor Greenleaf discussed concerns regarding Medicare Part B step therapy with FierceHealthcare
In The News ADVI’s Lindsay Bealor Greenleaf talks to Bloomberg Law about Drug Pricing Reform Expectations Under the 116th Congress
In The News ADVI’s Michael Kolodziej explains that the OCM could stimulate fine-tuned bundled payments and advance cancer care
In The News ADVI’s Dr. Michael Kolodziej on physician impact of the Administration’s IPI Plan
In The News ADVI director Lindsay Bealor Greenleaf talks changes to drug rebates and PBMs with the Washington Post
In The News ADVI CEO Marc Samuels On FDA Commissioner Gottlieb’s Comments Related to CAR-T Label Change
In The News Lindsay Bealor Greenleaf discusses the NDPC’s new pharmacy benefit contracting model with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf Discusses the Top Healthcare Takeaways from the Midterm Elections with Managed Healthcare Executive